To identify the LOX-1+ PMN-MDSCs among NPC survivors with CHB, NPC survivors without CHB, healthy controls, patients with CHB, and liver cirrhosis patients were used as controls. This evidence concerns the gene OLR1 and cirrhosis of liver.